Among the deadliest diseases in human history, Alzheimer's disease (AD) is a chronic neurodegenerative disorder that increases in seriousness over time. Changes in the brain start several decades before the development of AD, as an abnormal protein, beta-amyloid, start aggregating in the hippocampus area of the brain. At an early stage of AD, structural changes occur at the nanoscale level due to intracellular structural alterations. Hence, detecting nanoscale-level abnormalities early in the disease process is crucial for effective treatment. Dual optical/photonic techniques, Partial wave spectroscopy (PWS), and inverse participation ratio (IPR), are used to detect the nano to submicron scales structural alterations in the human brain cells/tissues due to AD.
|